Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 39, 2009 - Issue 2
95
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat

, , , , , & show all
Pages 125-134 | Received 05 Sep 2008, Accepted 05 Nov 2008, Published online: 01 Feb 2009

References

  • Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, et al. 2005. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. Journal of Clinical Investigation 115(5):1267–1274.
  • Asgeirsson D, Venturoli D, Fries E, Rippe B, Rippe C. 2007. Glomerular sieving of three neutral polysaccharides, polyethylene oxide and bikunin in rat. Effects of molecular size and conformation. Acta Physiologica (Oxford). 191(3):237–246.
  • Boehme MW, Galle P, Stremmel W. 2002. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107(3):340–349.
  • Ekholm R, Wollman SH. 1975. Site of iodination in the rat thyroid gland deduced from electron microscopic autoradiographs. Endocrinology 97(6):1432–1444.
  • Esmon CT. 1989. The roles of protein C and thrombomodulin in the regulation of blood coagulation. Journal of Biology and Chemistry 264:4743–4746.
  • Esmon CT. 2005. The interactions between inflammation and coagulation. British Journal of Haematology 131:417–430.
  • Esmon CT, Esmon NL, Harris KW. 1982b. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. Journal of Biology and Chemistry 257:7944–7947.
  • Esmon NL, Carroll RC, Esmon CT. 1983. Thrombomodulin blocks the activity of thrombin to activate platelets. Journal of Biology and Chemistry 258:12238–12242.
  • Esmon NL, Owen WG, Esmon CT. 1982a. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. Journal of Biology and Chemistry 257:859–864.
  • Fuentes-Prior P, Iwanaga Y, Huber R, Pagila R, Rumennik G, Seto M, et al. 2000. Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex. Nature 404:518–525.
  • Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, et al. 1992. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. Journal of Clinical Investigation 90(6):2565–2573.
  • Gomi K, Zushi M, Honda G, Kawahara S, Matsuzaki O, Kanabayashi T, et al. 1990. Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice. Blood 75:1396–1399.
  • Guasch A, Deen WM, Myers BD. 1993. Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. Journal of Clinical Investigation 92(5):2274–2282.
  • Honda G, Masaki C, Zushi M, Tsuruta K, Sata M. 1995. The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function. Journal of Biochemistry 118(5):1030–1036.
  • Ishii H, Majerus PW. 1985. Thrombomodulin is present in human plasma and urine. Journal of Clinical Investigation 76(6):2178–2181.
  • Ishikawa I, Hollenberg NK. 1976. Pharmacologic interruption of the renin–angiotensin system in myohemoglobinuric acute renal failure. Kidney International Supplement 6:S183–S190.
  • Levi M, Ten Cate H. 1999. Disseminated intravascular coagulation. New England Journal of Medicine 341:586–592.
  • Linehan SA, Martinez-Pomares L, Gordon S. 2000. Mannose receptor and scavenger receptor: two macropharge pattern recognition receptors with diverse function in tissue homeostasis and host defense. Advances in Experimental Medicine and Biology 479:1–14.
  • Malaba L, Kindberg GM, Norum KR, Berq T, Blomhoff R. 1993. Receptor-mediated endocytosis of retinol-binding protein by liver parenchymal cells: interference by radioactive iodination. Biochemistry Journal 291(1):187–191.
  • Marlar RA, Kleiss AJ, Griffin JH. 1982. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 59:1067–1072.
  • Maruyama I. 1999. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thrombosis and Haemostasis 82:718–721.
  • Moll S, Lindley C, Pescatore S, Morrison D, Tsuruta K, Mohri M, Serada M, Sata M, Shimizu H, Yamada K, White GC, II. 2004. Phase I study of a novel recombinant human soluble thrombomodulin, ART-123. Journal of Thrombosis and Haemostasis. 2(10):1745–1751.
  • Morrison AB. 1962. Experimentally induced chronic renal insufficiency in the rat. Laboratory Investigation 11:321–332.
  • Morrison AB. 1966. Experimentally chronic renal sufficiency. Methods and Achievements in Experimantal Pathology 1:455–475.
  • Nakashima M, Kanamaru M, Umemura K, Tsuruta K. 1998a. Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123, in healthy male volunteers. Journal of Clinical Pharmacology 38(1):40–44.
  • Nakashima M, Uematsu T, Umemura K, Maruyama I, Tsuruta K. 1998b. A novel recombinant soluble human thrombomodulin, ART-123, activates the protein C pathway in healthy male volunteers. Journal of Clinical Pharmacology 38(6):540–544.
  • Rennke HG, Venkatachalam MA. 1979. Glomerular permeability of macromolecules. Effect of molecular configuration on the fractional clearance of uncharged dextran and neutral horseradish peroxidase in the rat. Journal of Clinical Investigation 63(4):713–717.
  • Rippe C, Rippe A, Larsson A, Asgeirsson D, Rippe B. 2006. Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats. American Journal of Physiology and Renal Physiology 291(6):F1362–F1368.
  • Rippe C, Rippe A, Torffvit O, Rippe B. 2007. Size and charge selectivity of the glomerular filter in early experimental diabetes in rats. American Journal of Physiology and Renal Physiology 293(5):F1533–F1538.
  • Saito H, Maruyama I, Shimazaki S, Yamamoto Y, Aikawa N, Ohno R, et al. 2007. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. Journal of Thromb Heamost 5:31–41.
  • Salem H, Maruyama I, Ishii H, Majerus PW. 1984. Isolation and characterization of thrombomodulin from human placenta. Journal of Biology and Chemistry 259:12246–12251.
  • Stypinski D, Obaidi M, Combs M, Weber M, Stewart AJ, Ishikawa H. 2007. Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers. British Journal of Clinical Pharmacology 63(4):459–468.
  • Terpatra V, Van Amersfoort ES, Van Velzen AG, Kuiper J, Van Berkel TJ. 2000. Hepatic and extrahepatic scavenger receptors function in relation to disease. Arteriosclerosis and Thrombosis Vascular Biology 20:1860–1872.
  • Toh CH, Dennis M. 2003. Disseminated intravascular coagulation: old disease, new hope. British Medical Journal 327:974–977.
  • Wilson DR, Thiel G, Arce ML, Oken DE. 1967. Glycerol induced hemoglobinuric acute renal failure in the rat. 3. Micropuncture study of the effects of mannitol and isotonic saline on individual nephron function. Nephron 4(6):337–355.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.